IL6 and infection: During the acute phase of infection, a robust immune response is triggered, characterized by the release of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β) (26).